Sentence: Overall , our study shows that the combination of dabrafenib and cetuximab results in increased antitumor activity and decreased stem cell capacities in BRAF(V600E)-mutant CRC cells .
Drug combination annotation:
[{'class': 'POS', 'spans': ['dabrafenib', 'cetuximab'], 'is_context_needed': False}]